These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 18226657

  • 1. Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy.
    Jensen MP, Hoffman AJ, Stoelb BL, Abresch RT, Carter GT, McDonald CM.
    Arch Phys Med Rehabil; 2008 Feb; 89(2):320-8. PubMed ID: 18226657
    [Abstract] [Full Text] [Related]

  • 2. Changes in pain-related beliefs, coping, and catastrophizing predict changes in pain intensity, pain interference, and psychological functioning in individuals with myotonic muscular dystrophy and facioscapulohumeral dystrophy.
    Nieto R, Raichle KA, Jensen MP, Miró J.
    Clin J Pain; 2012 Jan; 28(1):47-54. PubMed ID: 21642844
    [Abstract] [Full Text] [Related]

  • 3. Impact of biopsychosocial factors on chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophy.
    Miró J, Raichle KA, Carter GT, O'Brien SA, Abresch RT, McDonald CM, Jensen MP.
    Am J Hosp Palliat Care; 2009 Jan; 26(4):308-19. PubMed ID: 19414560
    [Abstract] [Full Text] [Related]

  • 4. Pain location and intensity impacts function in persons with myotonic dystrophy type 1 and facioscapulohumeral dystrophy with chronic pain.
    Miró J, Gertz KJ, Carter GT, Jensen MP.
    Muscle Nerve; 2014 Jun; 49(6):900-5. PubMed ID: 24415580
    [Abstract] [Full Text] [Related]

  • 5. Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I.
    Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BG, Bleijenberg G.
    Acta Neurol Scand; 2007 Apr; 115(4):265-70. PubMed ID: 17376125
    [Abstract] [Full Text] [Related]

  • 6. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP, Conn KM, Smith J, Walker A, Parkhill AL, Hilbert JE, Luebbe EA, Moxley RT.
    J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
    [Abstract] [Full Text] [Related]

  • 7. Symptom burden in persons with myotonic and facioscapulohumeral muscular dystrophy.
    Smith AE, McMullen K, Jensen MP, Carter GT, Molton IR.
    Am J Phys Med Rehabil; 2014 May; 93(5):387-95. PubMed ID: 24247759
    [Abstract] [Full Text] [Related]

  • 8. Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy.
    Morís G, Wood L, FernáNdez-Torrón R, González Coraspe JA, Turner C, Hilton-Jones D, Norwood F, Willis T, Parton M, Rogers M, Hammans S, Roberts M, Househam E, Williams M, Lochmüller H, Evangelista T.
    Muscle Nerve; 2018 Mar; 57(3):380-387. PubMed ID: 29053898
    [Abstract] [Full Text] [Related]

  • 9. Quality of life and pain in patients with facioscapulohumeral muscular dystrophy.
    Padua L, Aprile I, Frusciante R, Iannaccone E, Rossi M, Renna R, Messina S, Frasca G, Ricci E.
    Muscle Nerve; 2009 Aug; 40(2):200-5. PubMed ID: 19609906
    [Abstract] [Full Text] [Related]

  • 10. Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD).
    Hamel J, Johnson N, Tawil R, Martens WB, Dilek N, McDermott MP, Heatwole C.
    Neurology; 2019 Sep 17; 93(12):e1180-e1192. PubMed ID: 31409737
    [Abstract] [Full Text] [Related]

  • 11. Experiences with bariatric surgery in patients with facioscapulohumeral dystrophy and myotonic dystrophy type 1: A qualitative study.
    Abel EEDH, Cup EHC, Lanser A, Leclercq WKG, Raaphorst J, Padberg GW, Satink T, Voermans NC.
    Neuromuscul Disord; 2018 Nov 17; 28(11):938-946. PubMed ID: 30342904
    [Abstract] [Full Text] [Related]

  • 12. The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
    Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BG, Bleijenberg G.
    J Psychosom Res; 2007 May 17; 62(5):571-9. PubMed ID: 17467412
    [Abstract] [Full Text] [Related]

  • 13. Chronic pain in persons with neuromuscular disease.
    Jensen MP, Abresch RT, Carter GT, McDonald CM.
    Arch Phys Med Rehabil; 2005 Jun 17; 86(6):1155-63. PubMed ID: 15954054
    [Abstract] [Full Text] [Related]

  • 14. Upper limb function and activity in people with facioscapulohumeral muscular dystrophy: a web-based survey.
    Bergsma A, Cup EH, Janssen MM, Geurts AC, de Groot IJ.
    Disabil Rehabil; 2017 Feb 17; 39(3):236-243. PubMed ID: 26942834
    [Abstract] [Full Text] [Related]

  • 15. Pain and the alpha-sleep anomaly: a mechanism of sleep disruption in facioscapulohumeral muscular dystrophy.
    Della Marca G, Frusciante R, Vollono C, Iannaccone E, Dittoni S, Losurdo A, Testani E, Gnoni V, Colicchio S, Di Blasi C, Erra C, Mazza S, Ricci E.
    Pain Med; 2013 Apr 17; 14(4):487-97. PubMed ID: 23387524
    [Abstract] [Full Text] [Related]

  • 16. If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).
    Hilbert JE, Kissel JT, Luebbe EA, Martens WB, McDermott MP, Sanders DB, Tawil R, Thornton CA, Moxley RT, Registry Scientific Advisory Committee.
    Contemp Clin Trials; 2012 Mar 17; 33(2):302-11. PubMed ID: 22155025
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and correlates of apathy in myotonic dystrophy type 1.
    Gallais B, Montreuil M, Gargiulo M, Eymard B, Gagnon C, Laberge L.
    BMC Neurol; 2015 Aug 22; 15():148. PubMed ID: 26296336
    [Abstract] [Full Text] [Related]

  • 18. Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial.
    Voet NB, Bleijenberg G, Padberg GW, van Engelen BG, Geurts AC.
    BMC Neurol; 2010 Jun 30; 10():56. PubMed ID: 20591139
    [Abstract] [Full Text] [Related]

  • 19. Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.
    Goselink RJM, Mul K, van Kernebeek CR, Lemmers RJLF, van der Maarel SM, Schreuder THA, Erasmus CE, Padberg GW, Statland JM, Voermans NC, van Engelen BGM.
    Neurology; 2019 Jan 22; 92(4):e378-e385. PubMed ID: 30568007
    [Abstract] [Full Text] [Related]

  • 20. Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations.
    Voermans NC, van der Bilt RC, IJspeert J, Hogrel JY, Jeanpierre M, Behin A, Laforet P, Stojkovic T, van Engelen BG, Padberg GW, Sacconi S, Lemmers RJLF, van der Maarel SM, Eymard B, Bassez G.
    J Neurol; 2019 Dec 22; 266(12):2987-2996. PubMed ID: 31471688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.